X

XenoHeart

Product

by United Therapeutics Corporation

Heard in 1 episode across 1 show since Sep 2026

XenoHeart is a genetically modified pig heart developed for cardiac xenotransplantation, intended to provide a potential alternative source of donor hearts for people with end-stage heart failure. It is an investigational biomedical product and is being developed through United Therapeutics’ xenotransplantation programs; it is not an approved commercial transplant product.

Episodes

1
across 1 show

First heard

Sep 2026

Expert statements

1
1 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20260
Sep 20261
Oct 20260

What experts have said about XenoHeart

1 statement · 1 positive

  1. Martine RothblattPositiveSep 15, 2026· Moonshots with Peter Diamandis

    United Therapeutics’ xenotransplanted hearts have kept two patients alive.

    “we've already proven that our hearts keep 2 patients alive.”

    Listen at 24:19

    Open the episode · Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

1 episode featuring XenoHeart, newest first

XenoHeart · PodLume